Multinationals challenge with new products

Published: 2008-01-08 07:00:00

Updated: 2008-01-08 07:00:00

Multinational pharmaceutical firms are seeking to rock the domestic market with 20-odd new drugs, although the successful listing of these medicines into the national health insurance appears to be uncertain.

Pfizer Korea will unveil three new drugs within this year following last year's intro...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK